Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Buy
55
TOI Quote, Financials, Valuation and Earnings
Last price:
$2.60
Seasonality move
:
2.74%
Day range:
$2.22 - $2.64
52-week range:
$0.13 - $3.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.51x
P/B ratio:
64.80x
Volume:
463K
Avg. volume:
1.3M
1-year change:
177.45%
Market cap:
$232.6M
Revenue:
$393.4M
EPS (TTM):
-$0.71
Earnings Data
Next earnings date for TOI
May 14
2025
Most recent earnings per share
-$0.14
Missed by $0.14
(Mar 24/2025)
Consensus Estimate
--
(Mar 24/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TOI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/24/2025 | Q4 | -- | $100.3M | -$0.14 | -- | -- |
| 11/13/2024 | Q3 | -- | $99.9M | -$0.18 | -- | -- |
| 08/13/2024 | Q2 | $103.3M | $98.6M | -$0.17 | -$0.10 | -$0.07 |
| 05/14/2024 | Q1 | $95.2M | $94.7M | -$0.22 | -$0.12 | -$0.10 |
| 03/27/2024 | Q4 | $82M | $85.8M | -$0.21 | -$0.11 | -$0.10 |
| 11/08/2023 | Q3 | $74.7M | $82M | -$0.19 | -$0.13 | -$0.06 |
| 08/08/2023 | Q2 | $73.8M | $80.2M | -$0.19 | -$0.17 | -$0.02 |
| 05/10/2023 | Q1 | $65M | $76.2M | -$0.33 | -- | -- |
| 03/09/2023 | Q4 | -- | $71.4M | -$0.15 | -- | -- |
| 11/09/2022 | Q3 | -- | $65M | -$0.17 | -- | -- |
| 08/09/2022 | Q2 | -- | $60.9M | -$0.06 | -- | -- |
| 05/11/2022 | Q1 | -- | $55.2M | $0.21 | -- | -- |
| 03/10/2022 | Q4 | -- | $52.3M | -$0.15 | -- | -- |
| 09/30/2021 | Q3 | -- | $52.3M | -$0.04 | -- | -- |
| 06/30/2021 | Q2 | -- | $49.8M | $0.05 | -- | -- |
| 03/31/2021 | Q1 | -- | $48.6M | -$0.02 | -- | -- |
| 12/31/2020 | Q4 | -- | $187.5M | -$0.13 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.08 | -- | -- |
| 06/30/2020 | Q2 | -- | $47.3M | $0.02 | -- | -- |
| 12/31/2018 | Q4 | -- | $37.4M | -$0.03 | -- | -- |
The Oncology Institute Earnings Questions
-
How Much did The Oncology Institute Generate in Revenue Last Quarter?
The Oncology Institute reported $100.3M worth of top line sales in its most recent quarter.
-
Did The Oncology Institute Beat Earnings Last Quarter?
The Oncology Institute announced earnings per share of -$0.14 which represents a miss of analyst forecast a -- per share.
-
Is The Oncology Institute Profitable?
The Oncology Institute reported $14.6M that represents $0.19 per share over the last quarter.
-
What is the Analyst Consensus for The Oncology Institute EPS Next Year?
The Oncology Institute's earnings are forecast to decrease from -$0.71 per share to -$0.51 per share next year representing a decrease of -54.35%.
-
When is The Oncology Institute's Earnings Date?
The Oncology Institute's next earnings date is May 14, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is up 34.66% over the past day.
Buy
63
SKX alert for May 7
Skechers USA [SKX] is down 0.07% over the past day.
